Gastro-enteropancreatic neuroendocrine tumor

Known as: Gastroenteropancreatic neuroendocrine tumor 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2018
02419992018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND/AIMS Neuroendocrine tumors (NETs) may originate from heterogeneous neuroendocrine cells. The incidence is increasing… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2017
2017
BACKGROUND/AIMS Somatostatin receptor (SSTR) scintigraphy (SRS) is the standard imaging modality for evaluation of… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2016
2016
AIM This study aimed to determine the degree of concordance between TNM staging used in the determination of the prognosis of… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2014
2014
The diagnostic management of a possible case of gastroenteropancreatic neuroendocrine tumor has much changed in the last 10 years… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2014
Review
2014
Aims: With the aim to improve peptide receptor radionuclide therapy effects in patients with gastroenteropancreatic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Pasireotide (SOM230), a novel multireceptor ligand somatostatin analog (SSA), binds with high affinity to four of the five… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2013
2013
According to the international guidelines, a multidisciplinary approach is currently advised for the optimal care of patients… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
BACKGROUND/AIMS The WHO 2010 grading system for gastroenteropancreatic neuroendocrine tumors(GEP-NETs) is used to evaluate the… (More)
Is this relevant?
2010
2010
PURPOSE Therapy with the somatostatin analogue DOTA-(0)-Phe(1)-Tyr(3)-octreotide (DOTATOC) labeled with a beta-(DOTA-Phe-Tyr… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
Nuclear factor-kappaB (NF-kappaB) is a transcription factor responsible for modulating the expression of many genes involved in… (More)
  • figure 2
  • table 1
  • table 2
  • figure 1
Is this relevant?